Investing.com - Chromadex Corp (NASDAQ: CDXC) reported first quarter EPS of $0.014, $0.04 better than the analyst estimate of $-0.023. Revenue for the quarter came in at $21.2M versus the consensus estimate of $20.81M.
Chromadex Corp's stock price closed at $1.740. It is up 29.850% in the last 3 months and up 7.410% in the last 12 months.
Chromadex Corp saw 1 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Chromadex Corp's stock price’s past reactions to earnings here.
According to InvestingPro, Chromadex Corp's Financial Health score is "great performance".
Check out Chromadex Corp's recent earnings performance, and Chromadex Corp's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar